查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1755829

血清分離凝膠市場成長、規模和趨勢分析：產品、最終用戶 - 區域展望、競爭策略和細分預測（至 2034 年）

Serum Separation Gel Market Growth, Size, Trends Analysis - By Product, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 250 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年全球血清分離凝膠市場規模將達到 160.5 億美元，複合年成長率為 7.16%。

血清分離膠是一種專用物質，用於在離心過程中將血清從全血中分離出來，並存放在採血管中。它通常由矽膠或惰性聚合物等凝膠材料構成，位於血清與促凝血劑層或抗凝血劑層之間。在離心過程中，凝膠充當屏障，將血球成分與血清物理隔離。

阻礙因素：含有血清分離膠的產品（尤其是採血管）價格高昂，會對醫療機構帶來沉重的財務負擔。尤其是在資源匱乏的醫療系統和資金不足的機構中，購買這些昂貴的產品可能會對實驗室設備、診斷工具和醫療服務的預算造成壓力，從而限制關鍵檢測能力的取得。

本報告調查了全球血清分離凝膠市場，並總結了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局以及主要企業的概況。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場動態

  • 促進因素、阻礙因素、機會與挑戰分析

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭態勢

  • 製造地、銷售區域、產品類型分佈
  • 併購、合作夥伴關係、產品發布和合作

第7章全球血清分離凝膠市場（依產品）

  • 無需採血管的血清分離膠
  • 血清分離膠及採血管

第8章全球血清分離凝膠市場（依最終用戶）

  • 醫院
  • 血庫
  • 製藥公司
  • 其他

第9章全球血清分離凝膠市場

  • 全球市場規模和市場佔有率

第 10 章全球血清分離凝膠市場（按地區）

  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亞
    • 其他
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美國
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他

第11章 公司簡介

  • Becton, Dickinson and Company
  • BIOSIGMA SpA
  • Bio-Rad Laboratories, Inc
  • Cardinal Health, Inc.
  • Danaher Corporation
  • FL MEDICAL srl
  • Greiner AG
  • Inter Vac Technology
  • Qiagen NV
  • Sekisui Chemical CO., LTD
  • 其他

第12章 結論

第13章簡稱表

第 14 章參考鏈接

簡介目錄
Product Code: HLCA25143

Serum Separation Gel Market Introduction and Overview

According to SPER market research, 'Global Serum Separation Gel Market Size- By Product, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Serum Separation Gel Market is predicted to reach 16.05 billion by 2034 with a CAGR of 7.16%.

Serum separation gel is a specialised substance found in blood collection tubes that helps to separate serum from whole blood during centrifugation. It is often made of gel materials such as silicone or inert polymers and positioned between the serum-free media layer and the clot activator or anticoagulant layer within the tube. During centrifugation, the gel serves as a barrier that separates serum from blood cells.

Restraints: The high cost of serum separation gel items, including blood collection tubes containing the gel, can place a considerable financial burden on healthcare facilities, especially in resource-constrained or underfunded systems. Purchasing serum separation gel solutions at high prices may put a strain on budgets for laboratory supplies, diagnostics, and healthcare services, limiting access to important testing capabilities.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By End User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Becton, Dickinson and Company, BIOSIGMA S.p.A, Bio-Rad Laboratories, Inc, Cardinal Health, Inc, Danaher Corporation, FL MEDICAL s.r.l, Greiner AG, InterVacTechnology, Qiagen N.V, Sekisui Chemical CO., LTD.

Global Serum Separation Gel Market Segmentation:

By Product: Based on the Product, Global Serum Separation Gel Market is segmented as; Serum Separation Gel Without Integrated Tubes, Serum Separation Gel with Integrated Tubes.

By End-User: Based on the End-User, Global Serum Separation Gel Market is segmented as; Hospitals, Blood Banks, Pharmaceutical Companies.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Serum Separation Gel Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Serum Separation Gel Market

7. Global Serum Separation Gel Market, By Product (USD Million) 2021-2034

  • 7.1. Serum separation gel without integrated tubes
  • 7.2. Serum separation gel with integrated tubes

8. Global Serum Separation Gel Market, By End-User (USD Million) 2021-2034

  • 8.1. Hospitals
  • 8.2. Blood banks
  • 8.3. Pharmaceutical companies
  • 8.4. Other end-users

9. Global Serum Separation Gel Market, (USD Million) 2021-2034

  • 9.1. Global Serum Separation Gel Market Size and Market Share

10. Global Serum Separation Gel Market, By Region, (USD Million) 2021-2034

  • 10.1. Asia-Pacific
    • 10.1.1. Australia
    • 10.1.2. China
    • 10.1.3. India
    • 10.1.4. Japan
    • 10.1.5. South Korea
    • 10.1.6. Rest of Asia-Pacific
  • 10.2. Europe
    • 10.2.1. France
    • 10.2.2. Germany
    • 10.2.3. Italy
    • 10.2.4. Spain
    • 10.2.5. United Kingdom
    • 10.2.6. Rest of Europe
  • 10.3. Middle East and Africa
    • 10.3.1. Kingdom of Saudi Arabia
    • 10.3.2. United Arab Emirates
    • 10.3.3. Qatar
    • 10.3.4. South Africa
    • 10.3.5. Egypt
    • 10.3.6. Morocco
    • 10.3.7. Nigeria
    • 10.3.8. Rest of Middle-East and Africa
  • 10.4. North America
    • 10.4.1. Canada
    • 10.4.2. Mexico
    • 10.4.3. United States
  • 10.5. Latin America
    • 10.5.1. Argentina
    • 10.5.2. Brazil
    • 10.5.3. Rest of Latin America

11. Company Profile

  • 11.1. Becton, Dickinson and Company
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary
    • 11.1.4. Recent developments
  • 11.2. BIOSIGMA S.p.A
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary
    • 11.2.4. Recent developments
  • 11.3. Bio-Rad Laboratories, Inc
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary
    • 11.3.4. Recent developments
  • 11.4. Cardinal Health, Inc.
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary
    • 11.4.4. Recent developments
  • 11.5. Danaher Corporation
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary
    • 11.5.4. Recent developments
  • 11.6. FL MEDICAL s.r.l
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary
    • 11.6.4. Recent developments
  • 11.7. Greiner AG
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary
    • 11.7.4. Recent developments
  • 11.8. Inter Vac Technology
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary
    • 11.8.4. Recent developments
  • 11.9. Qiagen N.V
    • 11.9.1. Company details
    • 11.9.2. Financial outlook
    • 11.9.3. Product summary
    • 11.9.4. Recent developments
  • 11.10. Sekisui Chemical CO., LTD
    • 11.10.1. Company details
    • 11.10.2. Financial outlook
    • 11.10.3. Product summary
    • 11.10.4. Recent developments
  • 11.11. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links